- Tofacitinib Impurity 4
-
- $0.00 / 10mg
-
2024-09-20
- CAS:923036-30-0
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
|
| 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- Basic information |
Product Name: | 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- | Synonyms: | N-Methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-;Tofacitinib-13;Tofacitinib impurity 9/N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine;N-Des(-3'-oxopropanenitrile)-N-(methyl)benzene Tofacitinib N-Hydrosulfonylmethylbenzene;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-me...;Azilsartan medoxomil impurity341;Tofatinib Impurity 4 | CAS: | 923036-30-0 | MF: | C27H31N5O2S | MW: | 489.63 | EINECS: | | Product Categories: | | Mol File: | 923036-30-0.mol | |
| 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- Chemical Properties |
Melting point | 180-183℃ | Boiling point | 655.2±65.0 °C(Predicted) | density | 1.27±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | pka | 9.02±0.10(Predicted) |
| 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- Usage And Synthesis |
Uses | A useful intermediate for the formal asymmetric synthesis of (+)?-?Tofacitinib. An impurity of Tofacitinib(C781351). |
| 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- Preparation Products And Raw materials |
|